Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|June 12, 2020
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimizationR B Verheijen, E L Swart, J H Beijnen, et al.
Iscience|June 9, 2025
A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailabilityMaurice A G M Kroon, Hanneke W M van Laarhoven, Eleonora L Swart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Potential drug interactions in cancer therapy: a prevalence study using an advanced screening methodR W F van Leeuwen, E L Swart, E Boven, et al.
Therapeutic Drug Monitoring|July 17, 2025
External Cross-validation of Two Ciprofloxacin Population Pharmacokinetic Models in Patients in Intensive CareIrma M Rigter, Eleonora L Swart, Roger J Brüggemann, et al.
British Journal of Clinical Pharmacology|October 13, 2011
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategyAbraham J Wilhelm, Peer de Graaf, Agnes I Veldkamp, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2005
Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltrationEleonora L Swart, Joost de Jongh, Klaas P Zuideveld, et al.
European Journal of Clinical Pharmacology|January 21, 2006
Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patientsEleonora L Swart, Klaas P Zuideveld, Joost de Jongh, et al.
British Journal of Clinical Pharmacology|January 30, 2004
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patientsEleonora L Swart, Klaas P Zuideveld, Joost de Jongh, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 5, 2007
Age is of influence on midazolam requirements in a paediatric intensive care unitDana-Anne H de Gast-Bakker, Suzanne D van der Werff, Renate Sibarani-Ponsen, et al.
European Journal of Clinical Pharmacology|February 8, 2019
Feasibility of and patients' perspective on nilotinib dried blood spot self-samplingChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Pageof 12